What are the ESMO recommendations for staging neuroendocrine tumors (NETs)?

Updated: Dec 23, 2018
  • Author: Evan S Ong, MD, MS; more...
  • Print


For staging of GEP-NETs, the ESM0 guidelines, updated in 2012, utilize the tumor-node-metastasis (TNM) classification created by the ENETS and the 2010 WHO grading system. [9] For staging of bronchopulmonary and thymus NETs, the ESMO prefers the AJCC system. [6] For adrenal carcinoma staging, the 2009 European Network for the Study of Adrenal Tumors (ENSAT) TNM system is recommended over the AJCC system. [10]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!